Menu
Your Cart

Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (1mL x 50 preps, Standard Edition)

Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (1mL x 50 preps, Standard Edition)
Secured Shopping
Best security features
Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (1mL x 50 preps, Standard Edition)

Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (Standard Edition) (50 preps)

  • Powered by Apostle MiniMax technology, Apostle MiniMax High Efficiency cfDNA Isolation Kit is an excellent tool for the isolation of ultra-low concentration cell free DNA (cfDNA). 
  • The superb performance of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit has been extensively validated.  Please review the examples of publications and performance data at: https://apostlebio.com/index.php?route=information/information&information_id=15 
  • Configuration: for 50 preps (processing 1 mL plasma each), or 25 preps (processing 2 mL plasma each).
  • Cat #: A17622-50.


Documentation:

Material Safety Data Sheet (MSDS):  http://www.apostlebio.com/minimax/minimax_material_safety_02.pdf


Protocol (manual):  https://www.apostlebio.com/minimax/minimax_protocol_v35_1x50_preps.pdf

Protocol (automated): https://www.apostlebio.com/doc/MagTouch-2000-cfDNA-extraction-2mL-4mL-plasma-protocol.pdf   

This product can be automated on an Apostle MagTouch Nucleic Acid Extraction Automation System, for details of the system, visit: https://apostlebio.com/index.php?route=product/category&path=59


For more information, visit: https://apostlebio.com/index.php?route=information/information&information_id=15 


This product series is also offered through Beckman Coulter Life Sciences.  Please visit the webpage below if you wish to order through Beckman Coulter:

https://www.beckman.com/reagents/genomic/dna-isolation/from-plasma 


$157.43
Using Apostle MiniMax cfDNA Isolation Technology a recent clinical study in 2821 myeloid or lymphoid neoplasm patients shows that liquid biopsy using targeted NGS is reliable in detecting chromosomal structural abnomalities in myeloid neoplasms. The study supports the use of liquid biopsy for early diagnosis and monitoring of patients with myeloid neoplasms. Read article